ABSTRACT
The purpose of development of this clinical practice guidelines was to provide evidence-based protocols that help the practitioner and the patient make the right decision for the health assessment, treatment and prevention of pneumoconiosis. Pneumoconiosis is the interstitial lung disease of occupational origin caused by prolonged inhalation of inorganic dust, characterized by chronic diffuse aseptic inflammation in lung tissue with the development of pulmonary fibrosis. Currently, thereare no treatment that provide a cure pulmonary fibrosis and changes in the dynamics of decline in lung function. Regular, individually tailored treatment should be directed to the pathogenic mechanisms and some clinical symptoms of pneumoconiosis, as well as the prevention of complications. To enhance the effect of pharmacotherapy is recommended to use non-drug therapies that enhance the functionality of the respiratory system.
Subject(s)
Occupational Diseases , Pneumoconiosis , Practice Guidelines as Topic/standards , Humans , Occupational Diseases/diagnosis , Occupational Diseases/prevention & control , Occupational Diseases/therapy , Pneumoconiosis/diagnosis , Pneumoconiosis/prevention & control , Pneumoconiosis/therapy , RussiaABSTRACT
The article presents information on activities of International Committee on Occupational medicine - history of its foundation, development and formation, main scientific goals and studies.
